SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta‐analysis

AIMS: This study aimed to determine the effects of sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) in heart failure with reduced ejection fraction (HFrEF), compare the effect of SGLT2i with angiotensin receptor neprilysin inhibitor (ARNI), and find whether combination of SGLT2i and ARNI is better...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yuling, Liu, Bin, Du, Jun, Wang, Jing, Jing, Xiaodong, Liu, Yajie, Deng, Songbai, Du, Jianlin, She, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120387/
https://www.ncbi.nlm.nih.gov/pubmed/33749159
http://dx.doi.org/10.1002/ehf2.13313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120387/
https://www.ncbi.nlm.nih.gov/pubmed/33749159
http://dx.doi.org/10.1002/ehf2.13313

Ejemplares similares